Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Børge G. Nordestgaard(Gentofte Hospital), Henry N. Ginsberg(Columbia University), E. Bruckert(Pitié-Salpêtrière Hospital), Rodrigo da Silva Santos(Universidade de São Paulo), Jan Albert Kuivenhoven(University Medical Center Groningen), Albert Wiegman(Amsterdam University Medical Centers), Olov Wiklund(Translational Therapeutics (United States)), P. Pajukanta(University of California, Los Angeles), Robert A. Hegele(Western University), Frederick J. Raal(University of the Witwatersrand), Jan Borén(Göteborgs Stads), Cathérine Boileau(Hôpital Necker-Enfants Malades), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Steve E. Humphries(University College London), Joep C. Defesche(Academic Medical Center), Maurizio Averna(Instituto di Biofisica), Gerald F. Watts(Royal Perth Hospital), Erik S.G. Stroes(Amsterdam University Medical Centers), Petri T. Kovanen(Wihuri Research Institute), Alberico L. Catapano(University of Milan), Olivier Descamps(Centre Hospitalier Universitaire de Tivoli), M. John Chapman(Sorbonne Université), KG Parhofer(Ludwig-Maximilians-Universität München), G. Kees Hovingh(Academic Medical Center), Anne Tybjærg‐Hansen(University of Copenhagen), Kausik K. Ray(Imperial College London), A.F.H. Stalenhoef(Radboud University Medical Center)
Cited by 2,733
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k